The Latest in B Cell Lymphoma

Chemo-free combo gets high response rate in relapsed or refractory DLBCL

July 23, 2019

Ibrutinib-venetoclax found highly active in hard-to-treat CLL

July 22, 2019

CAR T-cell therapy less effective in transformed follicular lymphoma

July 22, 2019

Flavopiridol elicits poor response in mantle cell lymphoma, DLBCL

July 18, 2019

Intravenous CNS chemo looks best for testicular DLBCL

July 17, 2019

On second thought, lenalidomide does improve DLBCL outcomes

July 15, 2019

Acalabrutinib extends PFS in advanced CLL

July 11, 2019

Ibrutinib tops chlorambucil against CLL

July 10, 2019

R2-CHOP doesn’t improve survival in DLBCL

July 10, 2019

CNS-directed therapy appears more effective for synDLBCL

July 9, 2019

No benefit with rituximab after first CR in DLBCL

July 5, 2019

Radiation bridging with axi-cel appears safe in DLBCL

July 5, 2019

Polatuzumab vedotin combo shows promise in DLBCL

July 5, 2019

Influenza vaccination status in DLBCL poorly documented

July 5, 2019

Rituximab and vemurafenib could challenge frontline chemotherapy for HCL

June 26, 2019

B Cell Lymphoma